TISSUE GLUE AND BIO ADHESIVE SEALANTS MARKET ANALYSIS

Tissue Glue And Bio-Adhesive Sealants Market, by Product Type (Protein Based Sealants, Collagen Based Sealants, Thrombin-based Sealants, Fibrin Sealant, Gelatin-based Sealant, Others), by Application(Cardiovascular Surgery, Laparoscopic Surgeries, Burns and Skin Grafting, Digestive, Cosmetic, Reconstructive and Hand Surgery, General Surgeries, Others), by End User(Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Global Tissue Glue and Bio-adhesive Sealants Market: Key Developments

In January 2020, Terumo Corporation is a medical technology company, introduced AQUABRID, its new surgical sealant solution launched specifically for aortic procedures, designed to achieve hemostasis even in the event of inhibited blood coagulation during cardiac surgery.

Global Tissue Glue and Bio-adhesive Sealants Market:

acquisition to expand the product portfolio of their manufacturer is expected to drive the global tissue glue and bio-adhesive sealants market growth over the forecast period. For instance, on October 5, 2022, Collagen Matrix, Inc. a regenerative medicine and a Linden Capital Partners portfolio company, announced the acquisition of Polyganics, B.V., a medical technology company that develops and manufactures bioresorbable medical devices. The acquisition expands Collagen Matrix’s portfolio of bioresorbable solutions and technology platforms for bone and tissue repair.